Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01034670 · ClinicalTrials.gov registry record · NA
Advanced Gastrointestinal Endoscopic Imaging
A NA study, sponsored by Stanford University.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT01034670: Clinical Trial NA study, sponsored by Stanford University.
NCT01034670 is a NA study that was terminated before completion, run by Stanford University. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01034670, a NA study, was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
To develop new methods to detect malignant and premalignant conditions of the gastrointestinal tract.
Interventions
- DEVICE Dual axis endoscopic microscope
- DEVICE wide field fluorescence system
- DEVICE CellVizio
- DRUG fluorescent Peptide
- DRUG fluorescein
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2009-06 |
| Est. Completion | 2017-09-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01034670
The ClinicalTrials.gov registry entry for NCT01034670 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Dual axis endoscopic microscope is the first listed.
NCT01034670 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01034670 about?
NCT01034670 is a clinical study titled "Advanced Gastrointestinal Endoscopic Imaging". To develop new methods to detect malignant and premalignant conditions of the gastrointestinal tract.
What is the current status of trial NCT01034670?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2009-06. Estimated completion is 2017-09-25.
What interventions are being tested in trial NCT01034670?
The interventions under investigation include: Dual axis endoscopic microscope (DEVICE), wide field fluorescence system (DEVICE), CellVizio (DEVICE), fluorescent Peptide (DRUG), fluorescein (DRUG).
Who is sponsoring clinical trial NCT01034670?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.